Navigation Links
Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid
Date:9/10/2009

p>

Amylin Forward-Looking Statements

This press release contains forward-looking statements about Amylin, which involve risks and uncertainties. The Company's actual results could differ materially from those discussed due to a number of risks and uncertainties, including that the phybrid program mentioned in this press release will not produce the results we expect, our clinical trials may not start when planned and/or confirm previous results; our preclinical studies may not be predictive; our product candidates may not receive regulatory approval; and inherent scientific, regulatory and other risks in the drug development and commercialization process. These and additional risks and uncertainties are described more fully in the Company's most recently filed SEC documents, including its Form 10-Q. Amylin undertakes no duty to update these forward-looking statements.

Biocon Forward-Looking Statements

Certain statements in this release concerning Biocon's future growth prospects are forward-looking statements, which are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those contemplated in such forward-looking statements. Important factors that could cause actual results to differ materially from our expectations include, amongst others general economic and business conditions in India, our ability to successfully implement our strategy, our research and development efforts, our growth and expansion plans and technological changes, changes in the value of the Rupee and other currency changes, changes in the Indian and international interest rates, change in laws and regulations that apply to the Indian and global biotechnology and pharmaceuticals industries, increasing competition in and the conditions of the Indian biotechnology and pharmaceuticals industries, changes in political conditions in India and changes in
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Amylin Pharmaceuticals Reports Second Quarter Financial Results
2. Amylin Pharmaceuticals to Present Compelling Efficacy and Safety Data From Diabetes Programs at ADA 2009
3. Amylin Announces Preliminary Results of Annual Meeting of Stockholders
4. Amylin Advises All Shareholders to Vote Their Blue Proxy Card Today
5. Three Independent Proxy Advisory Firms Support Stockholder Nominees in Amylin Proxy Fight
6. Amylin Issues Statement Regarding Open Letter From Icahn
7. Icahn Issues Open Letter to Amylin Shareholders
8. Amylin Sends Letter to Shareholders
9. Amylin Pharmaceuticals Reports First Quarter Financial Results
10. Letter From Carl Icahn to Amylin Pharmaceutical, Inc.
11. Amylin Pharmaceuticals to Webcast First Quarter Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...ire-FirstCall/ -- Centene Corporation (NYSE: C...ank of America Merrill Lynch 2009 Credit Conferenc...aza Hotel Times Square in New York City. ,, Cen...a.m. Eastern Time. Investors and other interested ...e,s presentation at: http://www.veracast.com/webc...
(Date:11/20/2009)...PRNewswire-USNewswire/ -- Samuel Gladding is no Sc...means to be "happy" during the holidays. As a lice...mily counseling and chair of the Department of Cou...esearch shows that it is the pressure to be happy ...ring the holidays. ,, That,s why he,s challengi...
(Date:11/20/2009)...wire-FirstCall/ -- SIRIUS XM Radio (Nasdaq: SIR... Radio Reports: What Every Women Needs to Know A...teran journalist Perri Peltz. ,, (Logo: http:...O ) ,, Doctor Radio Reports: What Every Woma...ber 21 live at 10:00 am ET on Doctor Radio , SIRI...
(Date:11/20/2009)...yde used for embalming in the funeral industry wer...myeloid leukemia, according to a new study publish...nal Cancer Institute . , Previous studies have s...ignancies and brain cancer in anatomists, patholog...y have worked with formaldehyde. , For this st...
(Date:11/20/2009)...Emergency medical service (EMS) providers in the U...rrests each year. Only 5 to 10 percent of people ...ality cardiopulmonary resuscitation (CPR) provided...th better patient outcome. The Resuscitation Outc...arch network to study prehospital treatments for c...
Breaking Medicine News(10 mins):Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5Health News:Funeral industry workers exposed to formaldehyde face higher risk of leukemia 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3
...ber 7 Misys (LSE: MSY), the,global application so...de,Processing product, for the second year in a ro...lution, Misys Confirmation Matching Service,(CMS) ...hnology,s readers were asked to vote on what they ...
... Opening a new, state-of-the-art cosm...d Reno, Nevada area, Dr. Tiffany McCormack hits th...n one of the nation’s leading publications. ...ive experience and credentials are generating buzz...
... Advances in prevention, detection an...ncer; Allsup honors cancer survivors by celebratin... Belleville, Ill. (PRWEB) November 7,...p , a national Social Security Disability Insuranc...
... Nov. 6 Zimmer Holdings, Inc.,(NYSE: ZMH ; SWX: ...ng,supporter of a new entity, created by the Ameri...ing for post-graduate orthopaedic fellowships and,...eive and analyze funding requests before making gr...
...PICK: Visualizing asthma-causing immune cells at w...central role in causing asthma. Now, a team of res..., has developed approaches to noninvasively visual...they hope that these approaches might be developed...
...WICK, N.J., Nov. 6 Savient,Pharmaceuticals, Inc. ...Clement, President and Chief Executive Officer of ...pdate at the upcoming Credit Suisse Phoenix,Health...rizona,Biltmore Resort, November 11-14, 2008., In...
Other Medicine News:Health News:Misys Wins 'Best Trade Processing Product' Accolade in European Banking Technology Readers' Choice Awards 2Health News:Dr. Tiffany McCormack in Reno, Nevada Named in Forbes Magazine as One of 10 Most Dependable Plastic Surgeons in the West 2Health News:Dr. Tiffany McCormack in Reno, Nevada Named in Forbes Magazine as One of 10 Most Dependable Plastic Surgeons in the West 3Health News:Dr. Tiffany McCormack in Reno, Nevada Named in Forbes Magazine as One of 10 Most Dependable Plastic Surgeons in the West 4Health News:More People Living Longer After Cancer Diagnosis 2Health News:Zimmer Holdings to Collaborate with the American Orthopaedic Association for Funding Post-Graduate Medical Education 2Health News:Zimmer Holdings to Collaborate with the American Orthopaedic Association for Funding Post-Graduate Medical Education 3Health News:JCI online early table of contents: Nov. 6, 2008 2Health News:JCI online early table of contents: Nov. 6, 2008 3Health News:JCI online early table of contents: Nov. 6, 2008 4Health News:JCI online early table of contents: Nov. 6, 2008 5Health News:Savient Pharmaceuticals to Present at the Credit Suisse Phoenix Healthcare Conference on November 13th 2
(Date:11/20/2009)...Newswire-FirstCall/ -- BD (Becton, Dickinson and C...ion of its acquisition of HandyLab, Inc., an Ann A...ufactures molecular diagnostic assays and automati...nnounced an exclusive agreement for BD to develop ... Jaguar(TM) platform, the first fully integrated m...
(Date:11/20/2009)...swire-FirstCall/ -- Soligenix, Inc. (OTC Bulletin ...known as DOR BioPharma, Inc., a late-stage biotech... a consortium to develop thermostable technology t...nes. Soligenix received a $9.4 million grant from ...iseases (NIAID), a division of the National Instit...
(Date:11/19/2009)...wswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc...a public offering of 5,000,000 shares of its commo...ceeds of $48.75 million. All of the shares are be...helf registration statement previously filed with ...has also granted the underwriters a 30-day option ...
Breaking Medicine Technology:BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3High Incidence of Obstructive Sleep Apnea in Suburban Dental Practices 50614 1High Incidence of Obstructive Sleep Apnea in Suburban Dental Practices 50614 2Unexpectedly long range effects in advanced magnetic devices 12876 1Orlowski of Albany to Become Head of Organ Donation Association 50613 1Orlowski of Albany to Become Head of Organ Donation Association 50613 2
...ide best science available, BETHESDA, Md., March ...y methodology for CNS clinical trials, United BioS... a European Advisory Board for,Data Quality. This ...ts,ongoing efforts to improve data quality and out...ements as pivotal endpoints, such as those in,psyc...
...Inc. (Nasdaq: ANSV ) today announced the initiati..., its long-acting, non-opioid analgesic,drug candi...The,multicenter, double-blind, placebo-controlled ...ea in reducing post-surgical pain in patients,unde...esigned to provide,pain relief for weeks to months...
Other Medicine Technology:UBC Forms European Advisory Board to Enhance Data Quality of CNS Trials 2UBC Forms European Advisory Board to Enhance Data Quality of CNS Trials 3Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy 2Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy 3Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy 4Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy 5
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
Medicine Products: